Humacyte (HUMA) Profit After Tax (2020 - 2026)
Humacyte (HUMA) reported Profit After Tax of -$17.6 million for Q1 2026, down 145.02% year-over-year from $39.1 million in Q1 2025, and up 28.97% quarter-over-quarter from -$24.8 million in Q4 2025.
Humacyte (HUMA) Profit After Tax (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has 7 years of Profit After Tax data on file, last reported at -$17.6 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$17.6 million, down 145.02% year-over-year; the trailing twelve-month figure through Mar 2026 was -$97.6 million (down 25.65% YoY), and the FY2025 annual result was -$40.8 million, up 72.54% from the prior year.
- Profit After Tax rose to -$17.6 million in Q1 2026 per HUMA's latest filing, from -$24.8 million in the prior quarter.
- Over five years, Profit After Tax peaked at $39.1 million in Q1 2025 and troughed at -$56.7 million in Q2 2024.
- A 5-year average of -$19.4 million and a median of -$24.8 million in 2025 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2022 and 2023: Profit After Tax jumped 314.37% in 2022, then sank 574.89% in 2023.
- A 5-year view of Profit After Tax shows it stood at -$3.7 million in 2022, then slumped by 574.89% to -$25.1 million in 2023, then climbed by 16.59% to -$20.9 million in 2024, then dropped by 18.45% to -$24.8 million in 2025, then advanced by 28.97% to -$17.6 million in 2026.
- Business Quant data shows HUMA's Profit After Tax at -$17.6 million in Q1 2026, -$24.8 million in Q4 2025, and -$17.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -56.74 Mn |
| 10 | Humacyte | 267.09 Mn | 218.55 Mn | -1.54 Mn | -17.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.62 Mn |
| Dec 31, 2025 | -24.80 Mn |
| Sep 30, 2025 | -17.51 Mn |
| Jun 30, 2025 | -37.66 Mn |
| Mar 31, 2025 | 39.14 Mn |
| Dec 31, 2024 | -20.94 Mn |
| Sep 30, 2024 | -39.20 Mn |
| Jun 30, 2024 | -56.66 Mn |
| Mar 31, 2024 | -31.90 Mn |
| Dec 31, 2023 | -25.11 Mn |
| Sep 30, 2023 | -26.00 Mn |
| Jun 30, 2023 | -22.71 Mn |
| Mar 31, 2023 | -36.97 Mn |
| Dec 31, 2022 | -3.72 Mn |
| Sep 30, 2022 | -25.28 Mn |
| Jun 30, 2022 | 36.87 Mn |
| Mar 31, 2022 | -19.83 Mn |
| Dec 31, 2021 | 42.59 Mn |
| Sep 30, 2021 | -31.56 Mn |
| Jun 30, 2021 | -17.20 Mn |